Progress of Clinical Research on Tacrolimus in Treatment of Myasthenia Gravis / 医药导报
Herald of Medicine
;
(12): 597-600, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-614300
ABSTRACT
Tacrolimus is a novel immunosuppressant used in the treatment of a variety of autoimmune diseases.More and more studies have shown that tacrolimus has a certain therapeutic effect on myasthenia gravis (MG).This article reviews the mechanism,clinical researches,adverse reactions,dosage and clinical evaluation of tacrolimus in the treatment of MG.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Herald of Medicine
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS